Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+14.84%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$12.9B
AUM Growth
+$2.06B
(+19%)
Cap. Flow
+$758M
Cap. Flow
% of AUM
5.86%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,047
New
43
Increased
776
Reduced
154
Closed
22
Top Buys
| 1 |
Tesla
TSLA
|
$58M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$39.4M |
| 3 |
Amazon
AMZN
|
$25.8M |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$24.3M |
| 5 |
Microsoft
MSFT
|
$23.8M |
Top Sells
| 1 |
Amgen
AMGN
|
$20.1M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$9.31M |
| 3 |
Estee Lauder
EL
|
$8.39M |
| 4 |
Colgate-Palmolive
CL
|
$6.31M |
| 5 |
Conagra Brands
CAG
|
$5.45M |
Sector Composition
| 1 | Technology | 23.27% |
| 2 | Consumer Discretionary | 12.53% |
| 3 | Healthcare | 12.45% |
| 4 | Financials | 11.19% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Kite Realty
KRG
$5.11B
| $435K | ﹤0.01% |
29,090
+3,707
| +15% | +$55.4K |
|
852
NVE Corp
NVEC
$323M
| $431K | ﹤0.01% |
7,664
+5,695
| +289% | +$320K |
|
853
Empire State Realty Trust
ESRT
$1.35B
| $425K | ﹤0.01% |
45,564
+536
| +1% | +$5K |
|
|
GAP
854
The Gap, Inc.
GAP
$8.83B
| $408K | ﹤0.01% |
20,189
+3,202
| +19% | +$64.7K |
|
|
ALEX
855
Alexander & Baldwin
ALEX
$1.41B
| $407K | ﹤0.01% |
+23,692
| New | +$407K |
|
856
Precigen
PGEN
$1.3B
| $407K | ﹤0.01% |
+39,915
| New | +$407K |
|
857
HF Sinclair
DINO
$9.56B
| $400K | ﹤0.01% |
15,475
+2,435
| +19% | +$62.9K |
|
858
Independence Realty Trust
IRT
$4.22B
| $399K | ﹤0.01% |
29,729
| – | – |
|
859
Acadia Realty Trust
AKR
$2.63B
| $396K | ﹤0.01% |
27,938
+332
| +1% | +$4.71K |
|
860
Rocket Pharmaceuticals
RCKT
$354M
| $391K | ﹤0.01% |
7,137
-2,998
| -30% | -$164K |
|
861
ImmunityBio
IBRX
$2.27B
| $388K | ﹤0.01% |
+29,101
| New | +$388K |
|
862
Intellia Therapeutics
NTLA
$1.29B
| $382K | ﹤0.01% |
7,026
-2,912
| -29% | -$158K |
|
863
Macerich
MAC
$4.74B
| $378K | ﹤0.01% |
35,408
+562
| +2% | +$6K |
|
864
Charles River Laboratories
CRL
$8.07B
| $375K | ﹤0.01% |
1,500
-137
| -8% | -$34.3K |
|
865
PagSeguro Digital
PAGS
$2.8B
| $368K | ﹤0.01% |
6,477
+730
| +13% | +$41.5K |
|
|
VRE
866
Veris Residential
VRE
$1.52B
| $368K | ﹤0.01% |
29,515
+3,501
| +13% | +$43.7K |
|
867
Ducommun
DCO
$1.35B
| $366K | ﹤0.01% |
6,810
-7,254
| -52% | -$390K |
|
|
OPI
868
Office Properties Income Trust
OPI
$16.7M
| $366K | ﹤0.01% |
16,104
+209
| +1% | +$4.75K |
|
869
Sangamo Therapeutics
SGMO
$165M
| $358K | ﹤0.01% |
22,962
+6,099
| +36% | +$95.1K |
|
870
Open Lending Corp
LPRO
$267M
| $354K | ﹤0.01% |
+10,134
| New | +$354K |
|
871
Omnicell
OMCL
$1.47B
| $351K | ﹤0.01% |
2,921
-634
| -18% | -$76.2K |
|
872
Krystal Biotech
KRYS
$4.35B
| $348K | ﹤0.01% |
5,808
+2,222
| +62% | +$133K |
|
873
Parsons
PSN
$8.08B
| $348K | ﹤0.01% |
9,567
+2,747
| +40% | +$99.9K |
|
874
CRISPR Therapeutics
CRSP
$4.99B
| $345K | ﹤0.01% |
2,256
-729
| -24% | -$111K |
|
875
ESCO Technologies
ESE
$5.23B
| $344K | ﹤0.01% |
3,329
+25
| +0.8% | +$2.58K |
|